24HourWire

24HourWire

News from all angles

MarketWatch Center

Summit Therapeutics’ stock tumbles again as FDA recommends new trial for lung-cancer drug

The U.S. regulator’s disclosure was more extensive than what the biotech company had announced Sunday.

Redirecting to MarketWatch in 3 seconds...

Read Now → Explore 24HourWire

Share this story with your network